An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera

Part of paid clinical trials in Houston, Texas.

Sponsor
Urmila DIwekar
Study ID
NCT07148999
Phase
PHASE1/PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Infertility (IVF Patients)

Eligibility Criteria

Sex
FEMALE
Age
20 Years - 50 Years
Healthy Volunteers
Accepted

Interventions

  • Opt-IVF — COMBINATION_PRODUCT
    Opt-IVF provides optimized dosage profile for each patient
  • Control — OTHER
    Physicians will decide the dosage for each day for patients

Study Details

A clinical trial will determine the effectiveness of using the Opt-IVF decision support tool for each patient's personalized and optimal drug dosage profile in the United States.

Key Dates

Start date
Sep 23, 2025
Status verified
Sep 2025
Primary completion
Feb 15, 2026
Completion
Feb 15, 2026

Study Design

Enrollment
200 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Control
    This arm will get dosage prescribed by the doctor
  • Experimental: Opt-IVF
    This arm patients will get dosage provided by Opt-IVF

Primary Outcome Measure

Total Gonadotropin Dosage [ Time Frame: Two weeks after the start of the cycle ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Positivf FertilityHoustonTexas77054
Paul Magarelli, MD, Ph.D.
[email protected]
719-331-6392
Positivf FertilitySan AntonioTexas78249
Francisco Arrendendo, MD, MPh
[email protected]
210-404-2229

Find similar trials in Houston, TX

By research site
Positivf Fertility· Houston, TXPositivf Fertility· San Antonio, TX

Related Studies